Novel aspects of autoantibodies to the PM/Scl complex: Clinical, genetic and diagnostic insights

Autoimmunity Reviews

Volumn 6, Issue 7, 2007, Pages 432-437

  Mahler, Michael ^a   Raijmakers, Reinout ^b  

^a Dr Fooke Laboratorien GmbH   (Germany)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Autoantibody; Exosome; PM Scl; Polymyositis; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; MESSENGER RNA; RECOMBINANT PROTEIN; RIBONUCLEASE; SCL 100 PROTEIN; SCL 75 PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; AUTOMATION; BINDING SITE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPLEX FORMATION; CORRELATION ANALYSIS; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; GENETIC ANALYSIS; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNODIFFUSION; IMMUNOFLUORESCENCE; POLYMYOSITIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REVIEW; RNA DEGRADATION; RNA PROCESSING; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CELL NUCLEOLUS; DERMATOMYOSITIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMYOSITIS; SCLERODERMA, SYSTEMIC;

EID: 34447502176     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.01.013     Document Type: Review

References (36)

1. von Muhlen C.A., and Tan E.M. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 24 (1995) 323-358
2. Arbuckle M.R., McClain M.T., Rubertone M.V., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349 (2003) 1526-1533
3. Ho K.T., and Reveille J.D. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5 (2003) 80-93
4. Wolfe J.F., Adelstein E., and Sharp G.C. Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest 59 (1977) 176-178
5. Treadwell E.L., Alspaugh M.A., Wolfe J.F., and Sharp G.C. Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen. J Rheumatol 11 (1984) 658-662
6. Reichlin M., Maddison P.J., Targoff I., et al. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol 4 (1984) 40-44
7. Schilders G., van Dijk E., Raijmakers R., and Pruijn G.J. Cell and molecular biology of the exosome: how to make or break an RNA. Int Rev Cytol 251 (2006) 159-208
8. Alderuccio F., Chan E.K., and Tan E.M. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex. J Exp Med 173 (1991) 941-952
9. Bluthner M., and Bautz F.A. Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein. J Exp Med 176 (1992) 973-980
10. Ge Q., Frank M.B., O'Brien C., and Targoff I.N. Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen. J Clin Invest 90 (1992) 559-570
11. Mahler M., Blüthner M., and Pollard K.M. Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. Clin Immunol 107 (2003) 65-79
12. Brouwer R., Vree Egberts W.T., Hengstman G.J., et al. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome. Arthritis Res 4 (2002) 134-138
13. Raijmakers R., Egberts W.V., van Venrooij W.J., and Pruijn G.J. The association of the human PM/Scl-75 autoantigen with the exosome is dependent on a newly identified N terminus. J Biol Chem 278 (2003) 30698-30704
14. Targoff I.N., and Reichlin M. Nucleolar localization of the PM-Scl antigen. Arthritis Rheum 28 (1985) 226-230
15. Gelpi C., Alguero A., Angeles Martinez M., Vidal S., Juarez C., and Rodriguez-Sanchez J.L. Identification of protein components reactive with anti-PM/Scl autoantibodies. Clin Exp Immunol 81 (1990) 59-64
16. Reimer G., Scheer U., Peters J.M., and Tan E.M. Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. J Immunol 137 (1986) 3802-3808
17. Oddis C.V., Okano Y., Rudert W.A., Trucco M., Duquesnoy R.J., and Medsger Jr. T.A. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. Arthritis Rheum 35 (1992) 1211-1217
18. Brouwer R., Hengstman G.J., Vree Egberts W., et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60 (2001) 116-123
19. Raijmakers R., Renz M., Wiemann C., et al. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome. Arthritis Rheum 50 (2004) 565-569
20. Mahler M., Raijmakers R., Dahnrich C., Bluthner M., and Fritzler M.J. Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen. Arthritis Res Ther 7 (2005) R704-R713
21. Selva-O'callaghan A., Labrador-Horrillo M., Solans-Laque R., Simeon-Aznar C.P., Martinez-Gomez X., and Vilardell-Tarres M. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum 55 (2006) 791-798
22. Vandergheynst F., Ocmant A., Sordet C., et al. Anti-pm/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clin Exp Rheumatol 24 (2006) 129-133
23. Warner N.Z., and Greidinger E.L. Patients with antibodies to both PmScl and dsDNA. J Rheumatol 31 (2004) 2169-2174
24. Borrows R., Chapel H., Steuer A., and Maidment G. Dysphagia associated with anti-PM-Scl antibodies in systemic lupus erythematosus. Scand J Rheumatol 35 (2006) 156-157
25. Beyne-Rauzy O., Fortenfant F., and Adoue D. Acquired haemophilia and PM-Scl antibodies. Rheumatology (Oxford) 39 (2000) 927-928
26. Jablonska S., and Blaszyk M. Scleromyositis (scleroderma/polimyositis overlap) is an entity. J Eur Acad Dermatol Venereol 18 (2004) 265-266
27. Marguerie C., Bunn C.C., Copier J., et al. The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl. Medicine 71 (1992) 327-336
28. Franceschini F., Cavazzana I., Generali D., et al. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J Rheumatol 29 (2002) 1393-1397
29. Kuwana M., Kaburaki J., Okano Y., Tojo T., and Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 37 (1994) 75-83
30. Hausmanowa-Petrusewicz I., Kowalska-Oledzka E., Miller F.W., et al. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 40 (1997) 1257-1266
31. Chinoy H., Salway F., Fertig N., et al. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res Ther 8 (2006) R13
32. O'Hanlon T.P., Carrick D.M., Targoff I.N., et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 85 (2006) 111-127
33. Blüthner M., Mahler M., Müller D.B., Dunzl H., and Bautz F.A. Identification of an alpha-helical epitope region on the PM/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides. J Mol Med 78 (2000) 47-54
34. Mahler M., Koenig M., Senécal J.L., et al. Sero-clinical aspects of autoantibodies to a PM/Scl peptide with special emphasis on a cohort of 495 systemic sclerosis patients. In: Shoenfeld Y., and Gershwin M.E. (Eds). Abstracts of 5th international congress on Autoimmunity (2006), Elsevier, Amsterdam, Boston 124
35. Van Eenennaam H., Vogelzangs J.H., Bisschops L., et al. Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations. Clin Exp Immunol 130 (2002) 532-540
36. Genth E., Mierau R., Genetzky P., et al. Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum 33 (1990) 657-665